Occudo Quantitative Strategies’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Occudo Quantitative Strategies's ELV Position: Q2 2026 in Review
Occudo Quantitative Strategies sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 5,654 shares — an estimated $2.13M sold.
Occudo Quantitative Strategies first reported a position in ELV in Q4 2020 and held it in 12 quarters. The position peaked at $3.53M in Q4 2024. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Occudo Quantitative Strategies reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Occudo Quantitative Strategies sold 5,654 Elevance Health shares in Q2 2026, an estimated $2.13M.
- Occudo Quantitative Strategies first reported a position in Elevance Health in Q4 2020 and held it in 12 quarters.
- Occudo Quantitative Strategies's Elevance Health position peaked at $3.53M in Q4 2024.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Occudo Quantitative Strategies's 13F filing for Q2 2026, filed 13 Aug 2026.